You can presume that a large percentage of that 40,000 weren't exposed to covid19 during the study.
I remember a year ago the Chinese shutting down a covid19 study in China because their infection rates went to zero.
I remember a year ago the Chinese shutting down a covid19 study in China because their infection rates went to zero.
Right now the efficacy numbers seem be affected by when and where the studies were done.
Scientifically it would've been the best idea.
The challenge now is that the more the world gets vaccinated the harder it gets to do any meaningful trial.
Because, if I am not mistaken, these studies are funded by the companies themselves.
So its really upto them if they want to do another trial, right? At least as per current law..